TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso, take a look at the leading medical stories of the week.
Today’s subjects consist of brand-new screening techniques for colorectal cancer, a drug-coated balloon for obstructed stents in the heart, delta-8 tetrahydrocannabinol (THC) usage, and death and dealt with attention-deficit/hyperactivity condition (ADHD).
Program notes:
0:39 How to deal with obstructed stents
1:40 Over a year does reblockage take place?
2:40 Bypass might be more resilient in some
3:00 Treating ADHD with medications and death
4:00 Mean age at medical diagnosis 17.4 years
5:00 Still, concerns stay
6:00 6% of youths around the world
6:25 THC and cannabis usage in youths in the U.S.
7:25 About 11% usage over preceding year
8:25 Similar to tianeptine and kratom?
9:10 Screening for colorectal cancer
10:10 Genomic changes detection
11:10 Stool sample gathered
12:06 End
Records:
Elizabeth: Can we enhance noninvasive colorectal cancer screening?
Rick: Treating obstructions in the heart arteries after a stent has actually been put.
Elizabeth: What is the death effect of dealing with ADHD?
Rick: And teen THC and cannabis usage in the United States.
Elizabeth: That’s what we’re discussing today on TTHealthWatch, your weekly take a look at the medical headings from Texas Tech University Health Sciences Center in El Paso. I’m Elizabeth Tracey, a Baltimore-based medical reporter.
Rick: I’m Rick Lange, president of Texas Tech University Health Sciences Center in El Paso, where I’m likewise Dean of the Paul L. Foster School of Medicine.
Elizabeth: Rick, I’m going to toss the ball to you. Which would you like to begin with?
Rick: How to deal with obstructions in the coronary arteries that have actually taken place and those that have actually had stents positioned. We have actually put over a million stents in the United States in the coronary arteries, and in general those stents are relatively reliable in not just right away easing the obstruction, however in long-lasting sturdiness.
10 percent of the time tissue grows inside the stent and a clog can repeat in the very first year after the stents have actually been positioned. In Europe, that’s treated with a drug-coated balloon. As soon as the balloon has actually been pumped up, that product abides by the within the artery and it’s indicated to avoid development of brand-new tissue once again. Research studies of this specific treatment have actually never ever been carried out in the United States. Even in Europe, the approval of this has actually been based upon fairly little research studies.
This is the biggest research study of what’s called a paclitaxel-coated versus an uncoated balloon in arteries with an obstruction after stent positioning. They took a look at 600 clients;